Global Pharmaceutical Contract Sales Outsourcing (CSO) Supply, Demand and Key Producers, 2023-2029

Publication Month: Feb 2023 | No. of Pages: 116 Published By: Global Info Research
Single User License: US $ 4480
Corporate User License: US $ 8960

Pharmaceutical Contract Sales Outsourcing (CSO), also known as Contract Sales Organization (CSO),means an Entity commonly and primarily known as a "contract sales organization" that is engaged primarily in the business of promoting products for third parties and is not, and is not a direct or indirect affiliate of, an entity commonly and primarily known as a "pharmaceutical", "biopharmaceutical" or "biotechnology" company; and (2) "Contract Sales Arrangement" shall mean an arrangement (that is terminable by the Company within three years without payment or penalty) between the Company and a Contract Sales Organization under which such Contract Sales Organization (A) would promote (and would only be granted such rights as are necessary to promote) a Company Pharmaceutical Product for a fee (which may be fixed or based upon a percentage of revenues or otherwise) but (B) would not be granted any research, development, manufacturing, sublicensing or other rights with respect to such Company Pharmaceutical Product or with respect to any Intellectual Property underlying or related to such Company Pharmaceutical Product except as necessary for the purpose of clause "(A)".
The Pharmaceutical Contract Sales Outsourcing (CSO) market covers Personal Promotion, Non-personal Promotion, Others, etc. The typical players include IQVIA, PHOENIX Group, Amplity Health, Ashfield Engage (Inizio), Syneos Health, EVERSANA, CMIC Group, EPS Corporation, etc.
This report studies the global Pharmaceutical Contract Sales Outsourcing (CSO) demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Pharmaceutical Contract Sales Outsourcing (CSO), and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pharmaceutical Contract Sales Outsourcing (CSO) that contribute to its increasing demand across many markets.
The global Pharmaceutical Contract Sales Outsourcing (CSO) market size is expected to reach $ 12470 million by 2029, rising at a market growth of 6.8% CAGR during the forecast period (2023-2029).
Global key players of pharmaceutical contract sales outsourcing include China Medical System (CMS), IQVIA, PHOENIX Group, EVERSANA, etc. The top five players hold a share over 40%.
Highlights and key features of the study
Global Pharmaceutical Contract Sales Outsourcing (CSO) total market, 2018-2029, (USD Million)
Global Pharmaceutical Contract Sales Outsourcing (CSO) total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Pharmaceutical Contract Sales Outsourcing (CSO) total market, key domestic companies and share, (USD Million)
Global Pharmaceutical Contract Sales Outsourcing (CSO) revenue by player and market share 2018-2023, (USD Million)
Global Pharmaceutical Contract Sales Outsourcing (CSO) total market by Type, CAGR, 2018-2029, (USD Million)
Global Pharmaceutical Contract Sales Outsourcing (CSO) total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Pharmaceutical Contract Sales Outsourcing (CSO) market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include China Medical System (CMS), IQVIA, PHOENIX Group, EVERSANA, Ashfield Engage (Inizio), Amplity Health, Sinco Pharma, Syneos Health and EPS Corporation, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pharmaceutical Contract Sales Outsourcing (CSO) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Pharmaceutical Contract Sales Outsourcing (CSO) Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Pharmaceutical Contract Sales Outsourcing (CSO) Market, Segmentation by Type
Personal Promotion
Non-personal Promotion
Others
Global Pharmaceutical Contract Sales Outsourcing (CSO) Market, Segmentation by Application
Pharmaceutical Company
Biotechnology Company
Generic Company
Others
Companies Profiled:
China Medical System (CMS)
IQVIA
PHOENIX Group
EVERSANA
Ashfield Engage (Inizio)
Amplity Health
Sinco Pharma
Syneos Health
EPS Corporation
Uniphar Group
CMIC Group
SciClone Pharmaceuticals
China Pioneer Pharma
Promoveo Health
CSO Pharmitalia
GTS Solution
QFR Solutions
Key Questions Answered
1. How big is the global Pharmaceutical Contract Sales Outsourcing (CSO) market?
2. What is the demand of the global Pharmaceutical Contract Sales Outsourcing (CSO) market?
3. What is the year over year growth of the global Pharmaceutical Contract Sales Outsourcing (CSO) market?
4. What is the total value of the global Pharmaceutical Contract Sales Outsourcing (CSO) market?
5. Who are the major players in the global Pharmaceutical Contract Sales Outsourcing (CSO) market?
6. What are the growth factors driving the market demand?

1 Supply Summary
1.1 Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
1.2 World Pharmaceutical Contract Sales Outsourcing (CSO) Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Pharmaceutical Contract Sales Outsourcing (CSO) Total Market by Region (by Headquarter Location)
1.3.1 World Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Pharmaceutical Contract Sales Outsourcing (CSO) Market Size (2018-2029)
1.3.3 China Pharmaceutical Contract Sales Outsourcing (CSO) Market Size (2018-2029)
1.3.4 Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Size (2018-2029)
1.3.5 Japan Pharmaceutical Contract Sales Outsourcing (CSO) Market Size (2018-2029)
1.3.6 South Korea Pharmaceutical Contract Sales Outsourcing (CSO) Market Size (2018-2029)
1.3.7 ASEAN Pharmaceutical Contract Sales Outsourcing (CSO) Market Size (2018-2029)
1.3.8 India Pharmaceutical Contract Sales Outsourcing (CSO) Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Pharmaceutical Contract Sales Outsourcing (CSO) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Pharmaceutical Contract Sales Outsourcing (CSO) Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 Demand Summary
2.1 World Pharmaceutical Contract Sales Outsourcing (CSO) Consumption Value (2018-2029)
2.2 World Pharmaceutical Contract Sales Outsourcing (CSO) Consumption Value by Region
2.2.1 World Pharmaceutical Contract Sales Outsourcing (CSO) Consumption Value by Region (2018-2023)
2.2.2 World Pharmaceutical Contract Sales Outsourcing (CSO) Consumption Value Forecast by Region (2024-2029)
2.3 United States Pharmaceutical Contract Sales Outsourcing (CSO) Consumption Value (2018-2029)
2.4 China Pharmaceutical Contract Sales Outsourcing (CSO) Consumption Value (2018-2029)
2.5 Europe Pharmaceutical Contract Sales Outsourcing (CSO) Consumption Value (2018-2029)
2.6 Japan Pharmaceutical Contract Sales Outsourcing (CSO) Consumption Value (2018-2029)
2.7 South Korea Pharmaceutical Contract Sales Outsourcing (CSO) Consumption Value (2018-2029)
2.8 ASEAN Pharmaceutical Contract Sales Outsourcing (CSO) Consumption Value (2018-2029)
2.9 India Pharmaceutical Contract Sales Outsourcing (CSO) Consumption Value (2018-2029)
3 World Pharmaceutical Contract Sales Outsourcing (CSO) Companies Competitive Analysis
3.1 World Pharmaceutical Contract Sales Outsourcing (CSO) Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Pharmaceutical Contract Sales Outsourcing (CSO) Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Pharmaceutical Contract Sales Outsourcing (CSO) in 2022
3.2.3 Global Concentration Ratios (CR8) for Pharmaceutical Contract Sales Outsourcing (CSO) in 2022
3.3 Pharmaceutical Contract Sales Outsourcing (CSO) Company Evaluation Quadrant
3.4 Pharmaceutical Contract Sales Outsourcing (CSO) Market: Overall Company Footprint Analysis
3.4.1 Pharmaceutical Contract Sales Outsourcing (CSO) Market: Region Footprint
3.4.2 Pharmaceutical Contract Sales Outsourcing (CSO) Market: Company Product Type Footprint
3.4.3 Pharmaceutical Contract Sales Outsourcing (CSO) Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 United States VS China VS Rest of the World (by Headquarter Location)
4.1 United States VS China: Pharmaceutical Contract Sales Outsourcing (CSO) Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Pharmaceutical Contract Sales Outsourcing (CSO) Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Pharmaceutical Contract Sales Outsourcing (CSO) Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Pharmaceutical Contract Sales Outsourcing (CSO) Consumption Value Comparison
4.2.1 United States VS China: Pharmaceutical Contract Sales Outsourcing (CSO) Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Pharmaceutical Contract Sales Outsourcing (CSO) Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Pharmaceutical Contract Sales Outsourcing (CSO) Companies and Market Share, 2018-2023
4.3.1 United States Based Pharmaceutical Contract Sales Outsourcing (CSO) Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, (2018-2023)
4.4 China Based Companies Pharmaceutical Contract Sales Outsourcing (CSO) Revenue and Market Share, 2018-2023
4.4.1 China Based Pharmaceutical Contract Sales Outsourcing (CSO) Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, (2018-2023)
4.5 Rest of World Based Pharmaceutical Contract Sales Outsourcing (CSO) Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Pharmaceutical Contract Sales Outsourcing (CSO) Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, (2018-2023)
5 Market Analysis by Type
5.1 World Pharmaceutical Contract Sales Outsourcing (CSO) Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Personal Promotion
5.2.2 Non-personal Promotion
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Type (2018-2023)
5.3.2 World Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Type (2024-2029)
5.3.3 World Pharmaceutical Contract Sales Outsourcing (CSO) Market Size Market Share by Type (2018-2029)
6 Market Analysis by Application
6.1 World Pharmaceutical Contract Sales Outsourcing (CSO) Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Pharmaceutical Company
6.2.2 Biotechnology Company
6.2.3 Generic Company
6.2.4 Others
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Application (2018-2023)
6.3.2 World Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Application (2024-2029)
6.3.3 World Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Application (2018-2029)
7 Company Profiles
7.1 China Medical System (CMS)
7.1.1 China Medical System (CMS) Details
7.1.2 China Medical System (CMS) Major Business
7.1.3 China Medical System (CMS) Pharmaceutical Contract Sales Outsourcing (CSO) Product and Services
7.1.4 China Medical System (CMS) Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 China Medical System (CMS) Recent Developments/Updates
7.1.6 China Medical System (CMS) Competitive Strengths & Weaknesses
7.2 IQVIA
7.2.1 IQVIA Details
7.2.2 IQVIA Major Business
7.2.3 IQVIA Pharmaceutical Contract Sales Outsourcing (CSO) Product and Services
7.2.4 IQVIA Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 IQVIA Recent Developments/Updates
7.2.6 IQVIA Competitive Strengths & Weaknesses
7.3 PHOENIX Group
7.3.1 PHOENIX Group Details
7.3.2 PHOENIX Group Major Business
7.3.3 PHOENIX Group Pharmaceutical Contract Sales Outsourcing (CSO) Product and Services
7.3.4 PHOENIX Group Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 PHOENIX Group Recent Developments/Updates
7.3.6 PHOENIX Group Competitive Strengths & Weaknesses
7.4 EVERSANA
7.4.1 EVERSANA Details
7.4.2 EVERSANA Major Business
7.4.3 EVERSANA Pharmaceutical Contract Sales Outsourcing (CSO) Product and Services
7.4.4 EVERSANA Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 EVERSANA Recent Developments/Updates
7.4.6 EVERSANA Competitive Strengths & Weaknesses
7.5 Ashfield Engage (Inizio)
7.5.1 Ashfield Engage (Inizio) Details
7.5.2 Ashfield Engage (Inizio) Major Business
7.5.3 Ashfield Engage (Inizio) Pharmaceutical Contract Sales Outsourcing (CSO) Product and Services
7.5.4 Ashfield Engage (Inizio) Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Ashfield Engage (Inizio) Recent Developments/Updates
7.5.6 Ashfield Engage (Inizio) Competitive Strengths & Weaknesses
7.6 Amplity Health
7.6.1 Amplity Health Details
7.6.2 Amplity Health Major Business
7.6.3 Amplity Health Pharmaceutical Contract Sales Outsourcing (CSO) Product and Services
7.6.4 Amplity Health Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Amplity Health Recent Developments/Updates
7.6.6 Amplity Health Competitive Strengths & Weaknesses
7.7 Sinco Pharma
7.7.1 Sinco Pharma Details
7.7.2 Sinco Pharma Major Business
7.7.3 Sinco Pharma Pharmaceutical Contract Sales Outsourcing (CSO) Product and Services
7.7.4 Sinco Pharma Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Sinco Pharma Recent Developments/Updates
7.7.6 Sinco Pharma Competitive Strengths & Weaknesses
7.8 Syneos Health
7.8.1 Syneos Health Details
7.8.2 Syneos Health Major Business
7.8.3 Syneos Health Pharmaceutical Contract Sales Outsourcing (CSO) Product and Services
7.8.4 Syneos Health Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Syneos Health Recent Developments/Updates
7.8.6 Syneos Health Competitive Strengths & Weaknesses
7.9 EPS Corporation
7.9.1 EPS Corporation Details
7.9.2 EPS Corporation Major Business
7.9.3 EPS Corporation Pharmaceutical Contract Sales Outsourcing (CSO) Product and Services
7.9.4 EPS Corporation Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 EPS Corporation Recent Developments/Updates
7.9.6 EPS Corporation Competitive Strengths & Weaknesses
7.10 Uniphar Group
7.10.1 Uniphar Group Details
7.10.2 Uniphar Group Major Business
7.10.3 Uniphar Group Pharmaceutical Contract Sales Outsourcing (CSO) Product and Services
7.10.4 Uniphar Group Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Uniphar Group Recent Developments/Updates
7.10.6 Uniphar Group Competitive Strengths & Weaknesses
7.11 CMIC Group
7.11.1 CMIC Group Details
7.11.2 CMIC Group Major Business
7.11.3 CMIC Group Pharmaceutical Contract Sales Outsourcing (CSO) Product and Services
7.11.4 CMIC Group Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 CMIC Group Recent Developments/Updates
7.11.6 CMIC Group Competitive Strengths & Weaknesses
7.12 SciClone Pharmaceuticals
7.12.1 SciClone Pharmaceuticals Details
7.12.2 SciClone Pharmaceuticals Major Business
7.12.3 SciClone Pharmaceuticals Pharmaceutical Contract Sales Outsourcing (CSO) Product and Services
7.12.4 SciClone Pharmaceuticals Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 SciClone Pharmaceuticals Recent Developments/Updates
7.12.6 SciClone Pharmaceuticals Competitive Strengths & Weaknesses
7.13 China Pioneer Pharma
7.13.1 China Pioneer Pharma Details
7.13.2 China Pioneer Pharma Major Business
7.13.3 China Pioneer Pharma Pharmaceutical Contract Sales Outsourcing (CSO) Product and Services
7.13.4 China Pioneer Pharma Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 China Pioneer Pharma Recent Developments/Updates
7.13.6 China Pioneer Pharma Competitive Strengths & Weaknesses
7.14 Promoveo Health
7.14.1 Promoveo Health Details
7.14.2 Promoveo Health Major Business
7.14.3 Promoveo Health Pharmaceutical Contract Sales Outsourcing (CSO) Product and Services
7.14.4 Promoveo Health Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Promoveo Health Recent Developments/Updates
7.14.6 Promoveo Health Competitive Strengths & Weaknesses
7.15 CSO Pharmitalia
7.15.1 CSO Pharmitalia Details
7.15.2 CSO Pharmitalia Major Business
7.15.3 CSO Pharmitalia Pharmaceutical Contract Sales Outsourcing (CSO) Product and Services
7.15.4 CSO Pharmitalia Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 CSO Pharmitalia Recent Developments/Updates
7.15.6 CSO Pharmitalia Competitive Strengths & Weaknesses
7.16 GTS Solution
7.16.1 GTS Solution Details
7.16.2 GTS Solution Major Business
7.16.3 GTS Solution Pharmaceutical Contract Sales Outsourcing (CSO) Product and Services
7.16.4 GTS Solution Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 GTS Solution Recent Developments/Updates
7.16.6 GTS Solution Competitive Strengths & Weaknesses
7.17 QFR Solutions
7.17.1 QFR Solutions Details
7.17.2 QFR Solutions Major Business
7.17.3 QFR Solutions Pharmaceutical Contract Sales Outsourcing (CSO) Product and Services
7.17.4 QFR Solutions Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 QFR Solutions Recent Developments/Updates
7.17.6 QFR Solutions Competitive Strengths & Weaknesses
8 Industry Chain Analysis
8.1 Pharmaceutical Contract Sales Outsourcing (CSO) Industry Chain
8.2 Pharmaceutical Contract Sales Outsourcing (CSO) Upstream Analysis
8.3 Pharmaceutical Contract Sales Outsourcing (CSO) Midstream Analysis
8.4 Pharmaceutical Contract Sales Outsourcing (CSO) Downstream Analysis
9 Research Findings and Conclusion
10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

Tables and Figures

List of Tables
Table 1. World Pharmaceutical Contract Sales Outsourcing (CSO) Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Pharmaceutical Contract Sales Outsourcing (CSO) Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Pharmaceutical Contract Sales Outsourcing (CSO) Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Pharmaceutical Contract Sales Outsourcing (CSO) Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Pharmaceutical Contract Sales Outsourcing (CSO) Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Pharmaceutical Contract Sales Outsourcing (CSO) Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Pharmaceutical Contract Sales Outsourcing (CSO) Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Pharmaceutical Contract Sales Outsourcing (CSO) Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Pharmaceutical Contract Sales Outsourcing (CSO) Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Pharmaceutical Contract Sales Outsourcing (CSO) Players in 2022
Table 12. World Pharmaceutical Contract Sales Outsourcing (CSO) Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Pharmaceutical Contract Sales Outsourcing (CSO) Company Evaluation Quadrant
Table 14. Head Office of Key Pharmaceutical Contract Sales Outsourcing (CSO) Player
Table 15. Pharmaceutical Contract Sales Outsourcing (CSO) Market: Company Product Type Footprint
Table 16. Pharmaceutical Contract Sales Outsourcing (CSO) Market: Company Product Application Footprint
Table 17. Pharmaceutical Contract Sales Outsourcing (CSO) Mergers & Acquisitions Activity
Table 18. United States VS China Pharmaceutical Contract Sales Outsourcing (CSO) Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Pharmaceutical Contract Sales Outsourcing (CSO) Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Pharmaceutical Contract Sales Outsourcing (CSO) Companies, Headquarters (States, Country)
Table 21. United States Based Companies Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Pharmaceutical Contract Sales Outsourcing (CSO) Revenue Market Share (2018-2023)
Table 23. China Based Pharmaceutical Contract Sales Outsourcing (CSO) Companies, Headquarters (Province, Country)
Table 24. China Based Companies Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Pharmaceutical Contract Sales Outsourcing (CSO) Revenue Market Share (2018-2023)
Table 26. Rest of World Based Pharmaceutical Contract Sales Outsourcing (CSO) Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Pharmaceutical Contract Sales Outsourcing (CSO) Revenue Market Share (2018-2023)
Table 29. World Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Type (2018-2023) & (USD Million)
Table 31. World Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Type (2024-2029) & (USD Million)
Table 32. World Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Application (2018-2023) & (USD Million)
Table 34. World Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Application (2024-2029) & (USD Million)
Table 35. China Medical System (CMS) Basic Information, Area Served and Competitors
Table 36. China Medical System (CMS) Major Business
Table 37. China Medical System (CMS) Pharmaceutical Contract Sales Outsourcing (CSO) Product and Services
Table 38. China Medical System (CMS) Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. China Medical System (CMS) Recent Developments/Updates
Table 40. China Medical System (CMS) Competitive Strengths & Weaknesses
Table 41. IQVIA Basic Information, Area Served and Competitors
Table 42. IQVIA Major Business
Table 43. IQVIA Pharmaceutical Contract Sales Outsourcing (CSO) Product and Services
Table 44. IQVIA Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. IQVIA Recent Developments/Updates
Table 46. IQVIA Competitive Strengths & Weaknesses
Table 47. PHOENIX Group Basic Information, Area Served and Competitors
Table 48. PHOENIX Group Major Business
Table 49. PHOENIX Group Pharmaceutical Contract Sales Outsourcing (CSO) Product and Services
Table 50. PHOENIX Group Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. PHOENIX Group Recent Developments/Updates
Table 52. PHOENIX Group Competitive Strengths & Weaknesses
Table 53. EVERSANA Basic Information, Area Served and Competitors
Table 54. EVERSANA Major Business
Table 55. EVERSANA Pharmaceutical Contract Sales Outsourcing (CSO) Product and Services
Table 56. EVERSANA Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. EVERSANA Recent Developments/Updates
Table 58. EVERSANA Competitive Strengths & Weaknesses
Table 59. Ashfield Engage (Inizio) Basic Information, Area Served and Competitors
Table 60. Ashfield Engage (Inizio) Major Business
Table 61. Ashfield Engage (Inizio) Pharmaceutical Contract Sales Outsourcing (CSO) Product and Services
Table 62. Ashfield Engage (Inizio) Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Ashfield Engage (Inizio) Recent Developments/Updates
Table 64. Ashfield Engage (Inizio) Competitive Strengths & Weaknesses
Table 65. Amplity Health Basic Information, Area Served and Competitors
Table 66. Amplity Health Major Business
Table 67. Amplity Health Pharmaceutical Contract Sales Outsourcing (CSO) Product and Services
Table 68. Amplity Health Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Amplity Health Recent Developments/Updates
Table 70. Amplity Health Competitive Strengths & Weaknesses
Table 71. Sinco Pharma Basic Information, Area Served and Competitors
Table 72. Sinco Pharma Major Business
Table 73. Sinco Pharma Pharmaceutical Contract Sales Outsourcing (CSO) Product and Services
Table 74. Sinco Pharma Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Sinco Pharma Recent Developments/Updates
Table 76. Sinco Pharma Competitive Strengths & Weaknesses
Table 77. Syneos Health Basic Information, Area Served and Competitors
Table 78. Syneos Health Major Business
Table 79. Syneos Health Pharmaceutical Contract Sales Outsourcing (CSO) Product and Services
Table 80. Syneos Health Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Syneos Health Recent Developments/Updates
Table 82. Syneos Health Competitive Strengths & Weaknesses
Table 83. EPS Corporation Basic Information, Area Served and Competitors
Table 84. EPS Corporation Major Business
Table 85. EPS Corporation Pharmaceutical Contract Sales Outsourcing (CSO) Product and Services
Table 86. EPS Corporation Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. EPS Corporation Recent Developments/Updates
Table 88. EPS Corporation Competitive Strengths & Weaknesses
Table 89. Uniphar Group Basic Information, Area Served and Competitors
Table 90. Uniphar Group Major Business
Table 91. Uniphar Group Pharmaceutical Contract Sales Outsourcing (CSO) Product and Services
Table 92. Uniphar Group Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Uniphar Group Recent Developments/Updates
Table 94. Uniphar Group Competitive Strengths & Weaknesses
Table 95. CMIC Group Basic Information, Area Served and Competitors
Table 96. CMIC Group Major Business
Table 97. CMIC Group Pharmaceutical Contract Sales Outsourcing (CSO) Product and Services
Table 98. CMIC Group Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. CMIC Group Recent Developments/Updates
Table 100. CMIC Group Competitive Strengths & Weaknesses
Table 101. SciClone Pharmaceuticals Basic Information, Area Served and Competitors
Table 102. SciClone Pharmaceuticals Major Business
Table 103. SciClone Pharmaceuticals Pharmaceutical Contract Sales Outsourcing (CSO) Product and Services
Table 104. SciClone Pharmaceuticals Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. SciClone Pharmaceuticals Recent Developments/Updates
Table 106. SciClone Pharmaceuticals Competitive Strengths & Weaknesses
Table 107. China Pioneer Pharma Basic Information, Area Served and Competitors
Table 108. China Pioneer Pharma Major Business
Table 109. China Pioneer Pharma Pharmaceutical Contract Sales Outsourcing (CSO) Product and Services
Table 110. China Pioneer Pharma Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. China Pioneer Pharma Recent Developments/Updates
Table 112. China Pioneer Pharma Competitive Strengths & Weaknesses
Table 113. Promoveo Health Basic Information, Area Served and Competitors
Table 114. Promoveo Health Major Business
Table 115. Promoveo Health Pharmaceutical Contract Sales Outsourcing (CSO) Product and Services
Table 116. Promoveo Health Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Promoveo Health Recent Developments/Updates
Table 118. Promoveo Health Competitive Strengths & Weaknesses
Table 119. CSO Pharmitalia Basic Information, Area Served and Competitors
Table 120. CSO Pharmitalia Major Business
Table 121. CSO Pharmitalia Pharmaceutical Contract Sales Outsourcing (CSO) Product and Services
Table 122. CSO Pharmitalia Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. CSO Pharmitalia Recent Developments/Updates
Table 124. CSO Pharmitalia Competitive Strengths & Weaknesses
Table 125. GTS Solution Basic Information, Area Served and Competitors
Table 126. GTS Solution Major Business
Table 127. GTS Solution Pharmaceutical Contract Sales Outsourcing (CSO) Product and Services
Table 128. GTS Solution Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. GTS Solution Recent Developments/Updates
Table 130. QFR Solutions Basic Information, Area Served and Competitors
Table 131. QFR Solutions Major Business
Table 132. QFR Solutions Pharmaceutical Contract Sales Outsourcing (CSO) Product and Services
Table 133. QFR Solutions Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 134. Global Key Players of Pharmaceutical Contract Sales Outsourcing (CSO) Upstream (Raw Materials)
Table 135. Pharmaceutical Contract Sales Outsourcing (CSO) Typical Customers
List of Figure
Figure 1. Pharmaceutical Contract Sales Outsourcing (CSO) Picture
Figure 2. World Pharmaceutical Contract Sales Outsourcing (CSO) Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Pharmaceutical Contract Sales Outsourcing (CSO) Total Market Size (2018-2029) & (USD Million)
Figure 4. World Pharmaceutical Contract Sales Outsourcing (CSO) Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Pharmaceutical Contract Sales Outsourcing (CSO) Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Pharmaceutical Contract Sales Outsourcing (CSO) Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Pharmaceutical Contract Sales Outsourcing (CSO) Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Pharmaceutical Contract Sales Outsourcing (CSO) Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Pharmaceutical Contract Sales Outsourcing (CSO) Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Pharmaceutical Contract Sales Outsourcing (CSO) Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Pharmaceutical Contract Sales Outsourcing (CSO) Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Pharmaceutical Contract Sales Outsourcing (CSO) Revenue (2018-2029) & (USD Million)
Figure 13. Pharmaceutical Contract Sales Outsourcing (CSO) Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Pharmaceutical Contract Sales Outsourcing (CSO) Consumption Value (2018-2029) & (USD Million)
Figure 16. World Pharmaceutical Contract Sales Outsourcing (CSO) Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Pharmaceutical Contract Sales Outsourcing (CSO) Consumption Value (2018-2029) & (USD Million)
Figure 18. China Pharmaceutical Contract Sales Outsourcing (CSO) Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Pharmaceutical Contract Sales Outsourcing (CSO) Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Pharmaceutical Contract Sales Outsourcing (CSO) Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Pharmaceutical Contract Sales Outsourcing (CSO) Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Pharmaceutical Contract Sales Outsourcing (CSO) Consumption Value (2018-2029) & (USD Million)
Figure 23. India Pharmaceutical Contract Sales Outsourcing (CSO) Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Pharmaceutical Contract Sales Outsourcing (CSO) by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Pharmaceutical Contract Sales Outsourcing (CSO) Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Pharmaceutical Contract Sales Outsourcing (CSO) Markets in 2022
Figure 27. United States VS China: Pharmaceutical Contract Sales Outsourcing (CSO) Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Pharmaceutical Contract Sales Outsourcing (CSO) Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Pharmaceutical Contract Sales Outsourcing (CSO) Market Size Market Share by Type in 2022
Figure 31. Personal Promotion
Figure 32. Non-personal Promotion
Figure 33. Others
Figure 34. World Pharmaceutical Contract Sales Outsourcing (CSO) Market Size Market Share by Type (2018-2029)
Figure 35. World Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Pharmaceutical Contract Sales Outsourcing (CSO) Market Size Market Share by Application in 2022
Figure 37. Pharmaceutical Company
Figure 38. Biotechnology Company
Figure 39. Generic Company
Figure 40. Others
Figure 41. Pharmaceutical Contract Sales Outsourcing (CSO) Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source




Companies Mentioned
China Medical System (CMS)
IQVIA
PHOENIX Group
EVERSANA
Ashfield Engage (Inizio)
Amplity Health
Sinco Pharma
Syneos Health
EPS Corporation
Uniphar Group
CMIC Group
SciClone Pharmaceuticals
China Pioneer Pharma
Promoveo Health
CSO Pharmitalia
GTS Solution
QFR Solutions

Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets